Clinical application of cDNA microarrays in oncology

Oncologist

Volumn 8, Issue 3, 2003, Pages 252-258

  Pusztai, Lajos ^a   Ayers, Mark ^b   Stec, James ^b   Hortobágyi, Gabriel N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

Microarrays; Predictive tests; Prognostic markers; Transcriptional profiling

Indexed keywords

COMPLEMENTARY DNA;

ACCURACY; DNA MICROARRAY; GENE EXPRESSION; GENE INTERACTION; GENETIC MARKER; HUMAN; METHODOLOGY; ONCOLOGY; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW;

DNA, NEOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RNA, NEOPLASM;

EID: 0038021562     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.8-3-252     Document Type: Review

References (33)

1. King HC, Sinha AA. Gene expression profile analysis by DNA microarrays: Promise and pitfalls. JAMA 2001;286:2280-2288.
2. Venter JC, Adams MD, Myers EW et al. The sequence of the human genome. Science 2001;291:1304-1351.
3. Golub TR, Slonim DK, Tamayo P et al Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999;286:531-537.
4. Eisen MB, Spellman PT, Brown PO et al. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998;95:14863-14868.
5. Wittes J, Friedman HP. Searching for evidence of altered gene expression: a comment on statistical analysis of microarray data. J Natl Cancer Inst 1999;91:400-401.
6. Baggerly KA, Coombes KR, Hess KR et al. Identifying differentially expressed genes in cDNA microarray experiments. J Comput Biol 2001;8:639-659.
7. Hwang D, Schmitt WA, Stephanopoulos G et al. Determination of minimum sample size and discriminatory expression patterns in microarray data. Bioinformatics 2002;18:1184-1193.
8. Mukherjee S, Tamayo P, Rogers S et al. Estimating data set size requirements for classifying DNA microarray data. J Comput Biol 2003 (in press).
9. Bast RC Jr, Ravdin P, Hayes DF et al. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001;19:1865-1878.
10. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
11. Perou CM, Sorlie T, Eisen MB et al. Molecular portraits of human breast tumours. Nature 2000;406:747-752.
12. Pusztai L, Ayers M, Stec J et al. Gene expression profiles obtained from single passage fine needle aspirations (FNA) of breast cancer reliably identify prognostic/predictive markers such as estrogen (ER) and HER-2 receptor status and reveal large scale molecular differences between ER-negative and ER-positive tumors. Clin Cancer Res 2003 (in press).
13. Gruvberger S, Ringner M, Chen Y et al Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res 2001;61:5979-5984.
14. Hedenfalk I, Duggan D, Chen Y et al. Gene-expression profiles in hereditary breast cancer. N Engl J Med 2001;344:539-548.
15. Alizadeh AA, Eisen MB, Davis RE et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-511.
16. Rosenwald A, Wright G, Chan WC et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002;346:1937-1947.
17. Nielsen TO, West RB, Linn SC et al. Molecular characterisation of soft tissue tumours: a gene expression study. Lancet 2002;359:1301-1307.
18. Pomeroy SL, Tamayo P, Gaasenbeek M et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 2002;415:436-442.
19. van't Veer LJ, Dai H, van de Vijver MJ et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530-536.
20. van de Vijver MJ, He YD, van't Veer LJ et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999-2009.
21. Takahashi M, Rhodes DR, Furge KA et al. Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc Natl Acad Sci USA 2001;98:9754-9759.
22. Beer DG, Kardia SL, Huang CC et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 2002;8:816-824.
23. Hofmann WK, de Vos S, Elashoff D et al. Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor ST1571 and gene-expression profiles: a gene-expression study. The Lancet 2002;359:481-486.
24. Chang JC, Wooten E, Elledghe RM et al. Gene expression profiles for docetaxel chemosensitivity. Proc Am Soc Clin Oncol 2002;21:1700a.
25. Ayers M, Symmans WF, Stec J et al. Gene expression profiling of fine needle aspirations of breast cancer identifies genes associated with complete pathologic response to neoadjuvant Taxol/FAC chemotherapy. Breast Cancer Res Treat 2002;76(suppl 1):64a.
26. Roche PC, Mertens ML, Couch FJ et al. Utilization of gene expression profiling to identify markers of disease recurrence in node-negative breast cancer. Breast Cancer Res Treat 2001;69:213a.
27. Alizadeh A, Eisen M, Davis RE et al. The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. Cold Spring Harb Symp Quant Biol 1999;64:71-78.
28. Symmans WF, Ayers M, Clark E et al. Fine needle aspiration and core needle biopsy samples of breast cancer provide similar total RNA yield, but different stromal gene expression profiles. Cancer 2003 (in press).
29. Hayes DF, Trock B, Harris AL. Assessing the clinical impact of prognostic factors: when is "statistically significant" clinically useful? Breast Cancer Res Treat 1998;52:305-319.
30. Loprinzi CL, Thome SD. Understanding the utility of adjuvant systemic therapy for primary breast cancer. J Clin Oncol 2001;19:972-979.
31. Ravdin PM, Siminoff IA, Harvey JA. Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy. J Clin Oncol 1998;16:515-521.
32. Carlson RW, Anderson BO, Bensinger W et al. NCCN Practice guidelines for breast cancer. Oncology (Huntingt) 2000;14:33-49.
33. Available at: http://consensus.nih.gov/cons/114/114_intro.htm